Association of Family Support, Patient Knowledge, and Drug Side Effects With Antiretroviral Therapy Adherence in HIV Patients
DOI:
https://doi.org/10.22437/jkmj.v9i3.45781Keywords:
HIV, Antiretroviral Therapy (ART), Treatment Adherence, Family Support, Drug Side EffectsAbstract
Effective antiretroviral therapy (ART) is essential for controlling HIV/AIDS; however, maintaining adherence remains challenging. Patient knowledge, family support, and drug side effects are recognized as factors association adherence. In Jambi Municipality, the increasing number of HIV cases highlights the need to identify determinants of ART adherence. This study to assess ART adherence and its associated factors among HIV patients in Jambi Municipality. This cross sectional study was conducted from July to October 2024 at Raden Mattaher Public Hospital and Simpang Kawat Community Health Center. A total of 144 HIV positive adults (≥18 years) who had been on ART for at least three months were selected through multistage sampling technique. Data were collected using a validated questionnaire measuring demographics, ART knowledge, family support, and side effects. Adherence was assessed using the Morisky Medication Adherence Scale (MMAS). Chi-square tests were used to determine associations. Most participants were male (85.4%) and aged 18–50 years (84%). More than half had good knowledge (56.3%) and adequate family support (63.2%), while 71.5% reported ART-related side effects. Overall, 79.9% demonstrated poor adherence. Bivariate analysis showed significant associations between ART adherence and knowledge, family support, as well as drug side effects (p < 0.001 for all variables). ART adherence in Jambi Municipality remains suboptimal. Interventions focusing on improving patient knowledge, strengthening family involvement, and managing treatment side effects are needed to enhance adherence and health outcomes for people living with HIV.
Downloads
References
1. United Nations on HIV/AIDS. FACT SHEET 2025 Global HIV statistics People living with HIV People living with HIV accessing antiretroviral therapy New HIV infections AIDS-related deaths People most affected by HIV. Unaids [Internet]. 2025;1–6. Available from: https://www.unaids.org/en/resources/fact-sheet
2. Fei LP, Zhao HH, Yang ZN, Wang S, Tang HL, Chen FF, et al. The association between disclosure and antiretroviral therapy among adults living with HIV in China: a systematic review and meta-analysis. BMC Infect Dis. 2025;25(1).
3. Ahmed AM, Sisay AL, Gebre MN. Incidence and predictors of loss to follow-up among adult HIV patients attending antiretroviral therapy at public health facilities in Agaro town, Southwest Ethiopia, 2023. BMC Infect Dis. 2025;25(1).
4. Wolelaw EH, Hiruy EG, Abdu AM, Mihretie KM. Incidence of death and its predictors among TB/HIV coinfected adult patients receiving anti-retroviral therapy at Gambelia referral hospital, Southwest Ethiopia, 2022. BMC Infect Dis [Internet]. 2025;25(1). Available from: https://doi.org/10.1186/s12879-025-10878-7
5. Gashema P, Iradukunda PG, Saramba E, Musafiri T, Umuhoza T, Ndahimana F, et al. Bridging the gap: identifying barriers and strategies for widespread implementation of long-acting injectable antiretroviral therapy in Sub-Saharan Africa: a scoping review. BMC Infect Dis. 2025;25(1).
6. Oryokot B, Kazibwe A, Oluka AI, Kagimu D, Bakashaba B, Ssentongo SM, et al. “Swallowing these drugs every day, you get tired”: a mixed-methods study to identify barriers and facilitators to retention and HIV viral load suppression among the adolescents living with HIV in TASO Mbale and TASO Soroti centers of excellence. AIDS Res Ther [Internet]. 2025;22(1). Available from: https://doi.org/10.1186/s12981-025-00719-7
7. Fan Z, Zheng S, Cui W, Zheng C, Sun Q, Yin J. Assessing HIV/AIDS patients’ access to antiretroviral drugs using the healthcare accessibility framework: a cross-sectional study from Shandong, China. BMC Infect Dis [Internet]. 2025;25(1). Available from: https://doi.org/10.1186/s12879-025-10567-5
8. Tsega TD, Tsega SS, Gebeyehu AA, Yemata GA, Anteneh RM, Yeshiwas AG, et al. Viral load suppression rate of third-line antiretroviral therapy and its association with gender among HIV patients after second-line treatment failure in Africa: a systematic review and meta-analysis. BMC Infect Dis. 2025;25(1).
9. Kawuma S, Katwesigye R, Walusaga H, Akatukunda P, Nangendo J, Kabugo C, et al. Determinants of continuation on HIV pre-exposure propylaxis among female sex workers at a referral hospital in Uganda: a mixed methods study using COM-B model. BMC Public Health [Internet]. 2025;25(1). Available from: https://doi.org/10.1186/s12889-024-20975-y
10. Ekwuofu AA, Dim OF, Adibe MO. Impact of differentiated care service delivery systems on adherence among the HIV-positive patients receiving antiretroviral therapy in a Southeastern Nigerian State. AIDS Res Ther [Internet]. 2025;22(1). Available from: https://doi.org/10.1186/s12981-024-00671-y
11. Chen H, Chen J, Zhao Q, Zhou M. Poppers use, adherence to antiretroviral therapy and risky sexual behaviors among HIV-positive men who have sex with men in Chongqing, China. Arch Public Heal [Internet]. 2025;83(1). Available from: https://doi.org/10.1186/s13690-025-01525-3
12. Koe Ngono A, Pokam Djoko GR, Ketchaji A, Mouenbori Sawi PC, Fodom Tchogang KC, Tengoche B, et al. Antiretroviral treatment failure and associated factors among people living with HIV at Logbaba district hospital, Cameroon. Discov Soc Sci Heal [Internet]. 2025;5(1). Available from: https://doi.org/10.1007/s44155-025-00192-7
13. Hailu G, Keraleme A, Zealiyas K, Tesema A, Nuramed N, Girmachew F, et al. Human Immunodeficiency Virus (HIV) viral load suppression status and associated factors among pregnant women receiving Highly Active Antiretroviral Therapy (HAART) in Ethiopia. Virol J [Internet]. 2025;22(1). Available from: https://doi.org/10.1186/s12985-025-02659-0
14. Chen YO, Safren SA. Non-Pharmacological Interventions Addressing Chronic Pain in People Living with HIV. Curr HIV/AIDS Rep. 2025;22(1).
15. Bazrafshan A, Rafiei-Rad AA, Bazrafshan MS, Ghalekhani N, Mehmandoost S, SeyedAlinaghi SA, et al. Facilitators and Barriers to adherence to antiretroviral therapy among incarcerated people living with HIV in Iran: insights from a qualitative study. Harm Reduct J. 2025;22(1).
16. Suwito A, Elfitri I, Afriwardi, Widya A, Afrizal, Hardisman, et al. Factors Influencing Non-Adherence to Antiretroviral Therapy among HIV/AIDS Patients in Western Sumatra: Implications for Practice in the Post-COVID-19 Era. Int J Des Nat Ecodynamics. 2024;19(1):311–20.
17. Shrestha S, Chataut S, Kc B, Acharya K, Pradhan SK, Shrestha S. Knowledge, Attitude, Practice, and Adherence to Antiretroviral Therapy among People Living with HIV in Nepal. AIDS Res Treat. 2023;2023.
18. Yunita EP, Wardani RNK, Sidharta B. Correlation between knowledge level, side effect severity, family support, and antiretroviral therapy adherence in HIV/AIDS patients in Greater Malang, East Java, Indonesia. Pharmacia. 2023;70(4):1213–22.
19. Jambi DiKK. Profil Dinas Kesehatan Kota Jambi. 2024.
20. Halim R, Kaur M, Mokhtar SSS, Chemi N, Sajatovic M, Tan YK, et al. The Association Between Medication Adherence, Internalized Stigma and Social Support Among Outpatients with Major Depressive Disorder in a Malaysian Hospital: A Cross-Sectional Study. Psychol Res Behav Manag. 2025;18(December 2024):209–23.
21. Wang X, Cheng Z. Cross-Sectional Studies: Strengths, Weaknesses, and Recommendations. Chest. 2020 Jul;158(1S):S65–71.
22. BPS. Badan Pusat Statistik Provinsi Jambi [Internet]. Badan Pusat Statistik. 2025 [cited 2025 Aug 10]. Available from: https://jambi.bps.go.id/id/statistics-table/2/MjEwOCMy/penduduk-menurut-kabupaten-kota-di-provinsi-jambi.html
23. Indonesia MOER. The Management Of National Education. 2015.
24. UNAIDS. UNAIDS Global Update 2022. 2022; Available from: https://www.unaids.org/sites/default/files/media_asset/2022-global-aids-update_en.pdf
25. Achappa B, Madi D, Bhaskaran U, Ramapuram JT, Rao S, Mahalingam S. Adherence to antiretroviral therapy among people living with HIV. N Am J Med Sci. 2023;5(3):220–3.
26. Glick JL, Huang A, Russo R, Jivapong B, Rosman L, Pelaez D, et al. ART Uptake and Adherence among Women who use Drugs Globally: A Scoping Review. Drug Alcohol Depend. 2021;
27. De las Cuevas C, Peñate W. Psychometric properties of the eight-item Morisky Medication Adherence Scale (MMAS-8) in a psychiatric outpatient setting. Int J Clin Heal Psychol. 2015;15(2):121–9.
28. Resref. Morisky Medication Adherence Scale-8 (MMAS-8): A Full Guide for Researchers and Clinicians [Internet]. Resref. 2025 [cited 2025 Aug 15]. Available from: https://resref.com/morisky-medication-adherence-scale-8-mmas-8-full-guide/
29. Elston DM. Study design and statistical analysis. Vol. 79, Journal of the American Academy of Dermatology. United States; 2018. p. 207.
30. Milandari NMS, Rismawan M, Rarayuni IGAR. Relationship Between Family Support with Compliance about the Treatment of Hypertension Patients. J EduHealth [Internet]. 2023;14(01):538–43. Available from: http://ejournal.seaninstitute.or.id/index.php/healt
31. Debra L. Nelson and James Campbell Quick. Social Support and Newcomer Adjustment in Organizations: Attachment Theory at Work? 12th ed. Vol. 12. Wiley; 1991. 543–554 p.
32. Chapola JC, Lee F, Bula A, Rosenberg NE, Tseka J, Chagomerana M, et al. Knowledge and perceptions about Dolutegravir and Dolutegravir counselling: a qualitative study among women living with HIV. BMC Womens Health. 2023;23(1):1–10.
33. Martiana I, Waluyo A, Yona S. Assessing the relationship between knowledge of antiretroviral therapy and stigma regarding adherence to ART among men who have sex with men. Enferm Clin. 2019;29:321–5.
34. Shrestha ML, Perry KE, Thapa B, Adhikari RP, Weissman A. Malnutrition matters: Association of stunting and underweight with early childhood development indicators in Nepal. Matern Child Nutr. 2022;18(2):2021.
35. Bandiera C, Ng R, Mistry SK, Harris E, Harris MF, Aslani P. The impact of interprofessional collaboration between pharmacists and community health workers on medication adherence: a systematic review. Int J Equity Health. 2025;24(1).
36. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Dep Heal Hum Serv [Internet]. 2024;1–334. Available from: https://clinicalinfo.hiv.gov/
37. Bella Safhira, Desheilla Andarini, Haerawati Idris RA. Factors Associated With HIV Adherence In Antiretroviral Therapy ; Literature Review. Endur J [Internet]. 2023;9(1):101–9. Available from: http://publikasi.lldikti10.id/index.php/endurance/issue/archive
38. Shrestha A, Poudel L, Shrestha S, Jha N, Kuikel BS, Shakya P, et al. Multilevel determinants of antiretroviral therapy initiation and retention in the test-and-treat era of Nepal: a qualitative study. BMC Health Serv Res. 2024;24(1).
39. Fassinou LC, Songwa Nkeunang D, Delvaux T, Nagot N, Kirakoya-Samadoulougou F. Adherence to option B + antiretroviral therapy and associated factors in pregnant and breastfeeding women in Sub-Saharan Africa: a systematic review and meta-analysis. BMC Public Health [Internet]. 2024;24(1). Available from: https://doi.org/10.1186/s12889-023-17004-9
40. Alhassan Y, Twimukye A, Malaba T, Myer L, Waitt C, Lamorde M, et al. “It’s only fatness, it doesn’t kill”: a qualitative study on perceptions of weight gain from use of dolutegravir-based regimens in women living with HIV in Uganda. BMC Womens Health. 2022;22(1):1–10.
41. Nankya I, Natukunda E, Rutebarika D, Matama C, Basiimwa R, Arikod P, et al. High prevalence of low-level viremia among infants initiated on antiretroviral drugs following mother-to-child transmission of HIV. AIDS Res Ther. 2025;22(1).
42. Buh A, Deonandan R, Gomes J, Krentel A, Oladimeji O, Yaya S. Barriers and facilitators to ART adherence among ART non-adherence people living with HIV in Cameroon: A qualitative phenomenological study. PLoS One [Internet]. 2023;18(9 September):1–17. Available from: http://dx.doi.org/10.1371/journal.pone.0291487
43. Department NYH. HIV Medication Managing Side E ects of [Internet]. Available from: https://www.health.ny.gov/publications/9408.pdf
44. Bagus Arisudhana GA, Sofro MAU, Sujianto U. Antiretroviral Side Effect on Adherence in People Living With Hiv Aids At Dr. Kariadi General Refferal Hospital Semarang Central Java. Nurse Media J Nurs. 2019;8(2):79.
45. Enslin D, Mallya P. Factors influencing treatment adherence in hypertension and HIV management in South Africa: A comparative literature review. South African Fam Pract. 2022;64(1):1–10.
46. Iweama CN, Agbaje OS, Umoke PCI, Igbokwe CC, Ozoemena EL, Omaka-Amari NL, et al. Nonadherence to tuberculosis treatment and associated factors among patients using directly observed treatment short-course in north-west Nigeria: A cross-sectional study. SAGE Open Med. 2021;9.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Rumita Ena Sari, Herwansyah Herwansyah, Hubaybah, Andika Aldi Putra (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Proposed Creative Commons Copyright Notices
1. Proposed Policy for Journals That Offer Open Access
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Proposed Policy for Journals That Offer Delayed Open Access
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication, with the work [SPECIFY PERIOD OF TIME] after publication simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
p-ISSN : 
e-ISSN : 
